| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |